Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive
and deadliest cancer worldwide, with an overall survival (OS) rate, all stages combined, of …

Prostate cancer is the most commonly diagnosed cancer and the second leading cause of
cancer-related death among men in western countries. Androgen deprivation therapy (ADT) …

The formation of pre-metastatic niche is a key step in the metastatic burden. The pluripotent
factor Lin28B is frequently expressed in breast tumors and is particularly upregulated in the …

Cancer immunology research is largely focused on the role of cytotoxic immune responses
against advanced cancers. Herein, we demonstrate that CD4+ T helper (Th2) cells directly …

Lung cancer is the leading cause of cancer death worldwide. Vaccination against EGFR can
be one of the venues to prevent lung cancer. Blocking glutamine metabolism has been …

Phototherapy is an important strategy to inhibit tumor growth and activate antitumor
immunity. However, the effect of photothermal/photodynamic therapy (PTT/PDT) is restricted …

Currently, there is no sensitive prognostic biomarker to screen out benefit patients from the
non-benefit population in advanced non-small cell lung cancer patients (aNSCLCs). The …

Background Cervical cancer (CC) is a disease that affects female health; therefore, timely
prevention and diagnosis of CC are crucial to decrease its mortality. Ferroptosis, an iron …

Blocking the PD-1/PD-L1 immune checkpoint has emerged as a promising strategy in
cancer immunotherapy, in which monoclonal antibodies are predominately used as …

Immune checkpoint inhibitors (ICIs), including anti-programmed cell death-1/anti-
programmed cell death ligand-1 (anti-PD-1/PD-L1) therapy, have elicited impressive clinical …